Canaccord Genuity on Biomedical Devices & Services: Japanese Exposure for Orthopedic Companies
Tweet
Share
E-mailGet Alerts WMGI Hot Sheet
Price: $29.98 --0%
Rating Summary:
9 Buy, 17 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 8 | Down: 5 | New: 26
Rating Summary:
9 Buy, 17 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 8 | Down: 5 | New: 26
Join SI Premium – FREE
Canaccord Genuity on Biomedical Devices & Services: Japanese Exposure for Orthopedic Companies - Extent of power conservation impact on semi-elective
procedures - replay of Katrina?
Canaccord analyst, Bill Plavonic, said, "We have grown more and more cautious on the Japanese MedTech market amid the growing concerns of power shortages impacting a larger portion of the population. In particular, we believe semi-elective procedures in orthopedics and sports medicine could be impacted in the areas hit by the tsunami, as well as in those areas experiencing power conservation and rolling blackouts. While we believe this impact would be only short term (impacting Q1/11 and Q2/11), we believe it could cause some weakness in near-term results for a few orthopaedic companies in particular. As far as exposure to Japan, we believe Wright Medical, Zimmer, Alphatec and Stryker are the most exposed."
"Wright Medical (Nasdaq: WMGI)(HOLD), Zimmer (Nasdaq: ZMH)(BUY), Alphatec (Nasdaq: ATEC)(BUY) and Stryker (NYSE: SYK)(BUY) could experience a headwind for the next few quarters."
procedures - replay of Katrina?
Canaccord analyst, Bill Plavonic, said, "We have grown more and more cautious on the Japanese MedTech market amid the growing concerns of power shortages impacting a larger portion of the population. In particular, we believe semi-elective procedures in orthopedics and sports medicine could be impacted in the areas hit by the tsunami, as well as in those areas experiencing power conservation and rolling blackouts. While we believe this impact would be only short term (impacting Q1/11 and Q2/11), we believe it could cause some weakness in near-term results for a few orthopaedic companies in particular. As far as exposure to Japan, we believe Wright Medical, Zimmer, Alphatec and Stryker are the most exposed."
"Wright Medical (Nasdaq: WMGI)(HOLD), Zimmer (Nasdaq: ZMH)(BUY), Alphatec (Nasdaq: ATEC)(BUY) and Stryker (NYSE: SYK)(BUY) could experience a headwind for the next few quarters."
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Viking Holdings (VIK) PT Raised to $82 at Mizuho
- Ferrovial SA (FER:SM) (FRRVF) Reiterated at Buy by UBS on Winning Bid For Tennessee Project
- Clear Street Reiterates Buy Rating on Anterix Inc. (ATEX)
Create E-mail Alert Related Categories
Analyst CommentsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
